CD4 and autoimmune disease: More importantly these peptides similar to their accompanying DRB1 presented peptides can activate autoreactive CD4+ T cells and provoke an autoimmune response which has been demonstrated by multiple studies where the DRB3, 4 and 5 restricted T cells are detected in measurable amount in patients with infectious and autoimmune diseases (49, 50).